MedPath

Sotalol Hydrochloride

These highlights do not include all the information needed to use SOTALOL HYDROCHLORIDE/SOTALOL HYDROCHLORIDE AF TABLETS safely and effectively. See full prescribing information for SOTALOL HYDROCHLORIDE/SOTALOL HYDROCHLORIDE AF TABLETS SOTALOL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1992 SOTALOL HYDROCHLORIDE AF tablets, for oral use Initial U.S. Approval: 1992

Approved
Approval ID

866e5717-3de2-4f19-b7c7-2275caeef78b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 24, 2021

Manufacturers
FDA

Major Pharmaceuticals

DUNS: 191427277

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sotalol Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0904-7143
Application NumberANDA076140
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sotalol Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 24, 2021
FDA Product Classification

INGREDIENTS (3)

Sotalol HydrochlorideActive
Quantity: 80 mg in 1 1
Code: HEC37C70XX
Classification: ACTIB
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Microcrystalline CelluloseInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sotalol Hydrochloride - FDA Drug Approval Details